TOP TIERMARKET NEWSWIRE
News & sentiment

NERVGEN PHARMA CORP (NGEN) — News & AI sentiment

NERVGEN PHARMA CORP (NGEN) news roundup. 1 story in the last 24 hours, 4 in the past week, 6 over 30 days. Average 24-hour sentiment is 48/100 — neutral (50 is neutral). No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 48/100
7d stories
4
avg sentiment 44.5/100
30d stories
6
avg sentiment 48.2/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

NGEN news in the last 24 hours, 7 days, 30 days and 90 days

How much NGEN coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowNGEN storiesAvg AI sentimentRead
Last 24 hours148/100NGEN headlines →
Last 7 days444.5/100NGEN headlines →
Last 30 days648.2/100NGEN headlines →
Last 90 days1250.4/100NGEN headlines →

Latest stories on NGEN

2d ago
2d ago
2d ago
2d ago
Sep 14
NervGen to Host Inaugural R&D Day on September 30, 2026
Business Insider56 · neutralproduct/pr
Sep 9
NG Energy International reports Q2 results
Seeking Alpha50 · neutralearnings
Aug 13
NervGen Pharma GAAP EPS of -C$0.37
Seeking Alpha34 · bearishearnings
Aug 13
Aug 13
Aug 13
Jul 27
Jul 2
Jun 11
Jun 1
May 26
Biggest stock movers Friday: WDAY, ZM, and more
Seeking Alpha55 · neutralgeneral
May 22
May 22
May 22
May 21
May 18
NervGen Pharma GAAP EPS of -$0.02
Seeking Alpha34 · bearishearnings
May 18
Open NGEN in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →